2014-03-17 05:49:04 - India Pharmaceuticals and Healthcare Report Q1 2014 - a new market research report on companiesandmarkets.com
Due to its large population and substantial unmet medical needs, India represents a market with strong commercial opportunities for pharmaceutical firms. However, we highlight that the government is impeding the development of its pharmaceutical sector, mainly due to extensive bureaucracy and poor policy planning. Some of the issues affecting various subsectors in the industry include the regulation of clinical trials, pricing of patented and essential drugs, generally low government involvement in healthcare and foreign direct investments.
Pharmaceuticals: INR840.0bn (US$15.7bn) in 2012 to INR904.0bn (US$16.1bn) in 2013; +7.7% in local currency terms and +2.7% in US dollar terms. Forecast was slightly downgraded from Q413 due to a slowdown in the pharmaceutical industry.
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market
Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.